These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9465321)

  • 1. [Clinical administration of hematopoietic growth factors. When and where?].
    Ottmann OG; Seipelt G; Hoelzer D
    Internist (Berl); 1997 Dec; 38(12):1160-7. PubMed ID: 9465321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth factors in oncology: effectiveness and prospects].
    Ottmann OG; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 6. [Integration of G-CSF in prevention and therapy of neutropenic fever].
    Siegmund R; Illiger HJ
    Med Klin (Munich); 1996 Feb; 91(2):82-8. PubMed ID: 8850103
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloid growth factors.
    Crawford J; Armitage J; Balducci L; Bennett C; Blayney DW; Cataland SR; Dale DC; Demetri GD; Erba HP; Foran J; Freifeld AG; Goemann M; Heaney ML; Htoy S; Hudock S; Kloth DD; Kuter DJ; Lyman GH; Michaud LB; Miyata SC; Tallman MS; Vadhan-Raj S; Westervelt P; Wong MK;
    J Natl Compr Canc Netw; 2009 Jan; 7(1):64-83. PubMed ID: 19176207
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
    Stull DM; Bilmes R; Kim H; Fichtl R
    Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemopoietic growth factors and childhood cancer.
    Hann IM
    Eur J Cancer; 1995; 31A(9):1476-8. PubMed ID: 7577075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth factors promote high-dose chemotherapy.
    Randall T
    JAMA; 1991 Dec; 266(21):2949-50. PubMed ID: 1726474
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential use of G-CSF and GM-CSF after heart-lung transplantation.
    Ippoliti G; Negri M; Rovati B; Grossi P; Viganó M
    J Heart Lung Transplant; 1997 Apr; 16(4):473-5. PubMed ID: 9154962
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Hübel K; Engert A
    Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colony stimulating factors in blood formation].
    Goebel M
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose versus standard-dose colony stimulating factor in patients with chemotherapy-induced febrile neutropenia.
    Burney IA; Salam A; Jat AA; Iqbal MP; Siddiqui T; Khan MA; Smego RA
    Oncology; 2003; 65(3):283-4. PubMed ID: 14657603
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactive discussion on chemotherapy-related adverse events.
    Adams VR; Lyman GH
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of hematopoietic growth factors in elderly patients receiving cytotoxic chemotherapy.
    Bokemeyer C; Honecker F; Wedding U; Späth-Schwalbe E; Lipp HP; Kolb G;
    Onkologie; 2002 Feb; 25(1):32-9. PubMed ID: 11893881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective comparison of three different methods for mobilization of peripheral blood stem cells.
    Mangan KF; Mullaney MT; Klumpp TR; Goldberg SL; Macdonald JS
    Prog Clin Biol Res; 1994; 389():441-8. PubMed ID: 7535452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.